Tci Hospital VTE Quiz

Mechanical compression with graduated compression stockings and/or intermittent pneumatic compression reduces the risk of developing a VTE (venous thromboembolism) by improving blood flow and preventing blood from pooling or clotting in the veins. Graduated compression stockings apply pressure that is highest at the ankles and gradually decreases towards the top, helping to push blood back up towards the heart. Intermittent pneumatic compression devices use inflatable cuffs to compress and release the legs, further promoting blood flow. These interventions are commonly used in healthcare settings for patients at risk of VTE, such as those undergoing surgery or immobilized for long periods.

When a patient has a confirmed acute DVT, they should wear class 2 graduated compression stockings. These stockings are designed to apply pressure to the legs, helping to improve blood flow and prevent blood clots from forming or getting worse. This can be particularly beneficial for patients with DVT as it can reduce swelling, pain, and the risk of complications such as pulmonary embolism. Wearing nothing, coloured stockings, or tall socks would not provide the same level of compression and support needed for DVT treatment.

Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a common, lethal disorder that affects hospitalized and nonhospitalized patients, recurs frequently, is often overlooked, and results in long-term complications including chronic thromboembolic pulmonary hypertension (CTPH) and the post-thrombotic syndrome (PTS).

Graduate compression stockings are an appropriate venous thromboembolism (VTE) prevention strategy for the patient at moderate risk. This means that for patients who have a moderate risk of developing VTE, using graduate compression stockings can be an effective preventive measure. It suggests that other strategies may be more suitable for patients at high risk or that graduate compression stockings may not be effective for patients at low risk.

All medications ordered for VTE prophylaxis must be documented in the patient's medical record and patient prescription module. This ensures that the information is readily available to healthcare providers and can be easily accessed for future reference. The patient's medical record contains a comprehensive history of their healthcare, including all medications prescribed. The patient prescription module is a specific section within the medical record that is dedicated to documenting the medications prescribed to the patient. By documenting the VTE prophylaxis medications in both the medical record and prescription module, there is a clear record of the prescribed treatment plan for VTE prophylaxis.

High risk patients are categorized as having cancer, prior VTE (venous thromboembolism), or known thrombophilia. This means that patients who have any of these conditions are considered to be at a higher risk for developing blood clots. It is important to identify these high-risk individuals so that appropriate preventive measures can be taken to reduce their risk of complications.

Dr. Denise Braithwaite- Tennant is the ROP team lead for VTE

The TCI hospital's VTE risk assessment tool requires the patient's name, date of birth, and gender to complete the patient's demographics. However, marital status is not required for this assessment.

The correct answer is a. Early and frequent mobilization. This is because patients with VTE (venous thromboembolism) are at risk for blood clots, and early and frequent mobilization helps to prevent these clots from forming or getting worse. Moving around and exercising the legs helps to improve blood flow and prevent stagnation, reducing the risk of clots. Additionally, mobilization can also help to improve overall recovery and prevent complications such as muscle weakness or joint stiffness.

The correct answer is d. All of the above. This means that all of the statements mentioned in options a, b, and c are included in the TCI Hospital VTE policy. This includes evaluating patients for VTE risk upon admission, providing education on VTE risk and symptoms, promoting early mobilization, and administering pharmacologic thromboprophylaxis to high-risk patients unless contraindicated.

A thrombus or clot can develop through a combination of factors. Alterations to blood flow can cause venous stasis, which can lead to the formation of a thrombus. Injury to the vascular endothelium can also trigger the clotting process. Additionally, alterations to the constitution of blood, such as hypercoagulability, can increase the risk of clot formation. Therefore, all of the above factors contribute to the development of a thrombus or clot.

The correct answer is d. "All of the above." This means that all of the special scenarios mentioned in options a, b, and c are considered contraindications to prophylaxis. Heparin-induced thrombocytopenia may require the consideration of an alternative medication like fondaparinux. If the length of stay is anticipated to be less than or equal to 48 hours, prophylaxis may not be necessary. If a patient has an epidural catheter or spinal block, special precautions need to be taken when considering VTE prophylaxis.

Acute stroke should be considered when screening for bleeding risk factors at admission because it is a medical condition that can increase the risk of bleeding. Acute stroke can cause damage to blood vessels in the brain, leading to bleeding or hemorrhage. This can be a significant risk factor for patients, as it can result in complications and worsen their overall health. Therefore, it is important to consider acute stroke as a potential bleeding risk factor when screening patients at admission.

Policy :- CPNUR 110
5.2 Risk of thromboembolism and risk for bleeding should be assessed in all patients at admission and as changes in clinical status occur

A history of VTE (Venous Thromboembolism) refers to a previous occurrence of blood clots in the veins. This is considered the greatest risk factor because individuals who have had a VTE in the past are more likely to have another one in the future. The risk increases with each occurrence, and preventive measures should be taken to reduce the chances of developing further blood clots. Dehydration, long haul flights, and oral contraception are also risk factors for VTE, but they are not as significant as having a history of VTE.

The usual prophylactic dose of Enoxaparin for a medical patient is 40mg subcutaneously every 12 hours. This dosage is commonly prescribed to prevent blood clots in patients who are at risk due to medical conditions or procedures. It is important to administer the medication at the correct intervals to ensure its effectiveness in preventing clot formation.

Active bleeding is considered an absolute contraindication to prophylaxis in medical, surgical/trauma patients because it can increase the risk of further bleeding and complications. Prophylaxis involves the use of medications or interventions to prevent a particular condition or complication. In the case of active bleeding, it is important to address the bleeding first before considering prophylaxis to prevent any potential harm or worsening of the bleeding.

A 78 year old morbidly obese woman who is having elective knee surgery would have to be monitored for a higher risk of bleeding. Age, obesity, and elective surgery are all factors that can increase the risk of bleeding. Additionally, knee surgery can involve cutting into blood vessels, which further increases the risk of bleeding. Therefore, this patient would require closer monitoring for any signs of bleeding during and after the surgery.

VTE risk assessments are carried out on patients who are eighteen years and older. This means that patients who are at least eighteen years old are evaluated for their risk of developing venous thromboembolism (VTE), a condition where blood clots form in the veins. By conducting these assessments, healthcare professionals can identify individuals who may be at a higher risk for VTE and take appropriate preventive measures to reduce the chances of clot formation.

Patients who undergo total hip arthroplasty are at high risk for developing venous thromboembolism (VTE) due to the surgical procedure and immobility post-surgery. Extended VTE prophylaxis for up to 35 days is recommended in these patients to prevent the occurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE). Ischaemic stroke, major surgery with age less than 60 years, and major surgery with age greater than 40 years do not have specific indications for extended VTE prophylaxis.

The correct answer is c. Previous history of VTE. This is a contradiction to the definition of low risk because a previous history of VTE (Venous Thromboembolism) indicates a higher risk for developing blood clots. Low risk typically refers to individuals who do not have any previous history or risk factors for developing VTE.

The given conditions, such as age over 35 years, obesity, parity of 3 or more, being a smoker, having gross varicose veins, and having a current systemic infection, are all risk factors for developing complications during pregnancy. Antenatal prophylaxis with LMWH (low molecular weight heparin) is a preventive measure that can be taken to reduce the risk of blood clots and other complications in these high-risk patients. Therefore, it is recommended to consider antenatal prophylaxis with LMWH for antenatal patients with three or more of these conditions.

The appropriate intervention for a postnatal high risk patient is to administer at least 6 weeks of postnatal prophylactic LMWH (Low Molecular Weight Heparin). This intervention helps prevent the formation of blood clots, which is a common risk for postnatal patients. LMWH is a medication that helps thin the blood and reduce the risk of clotting. By administering it for at least 6 weeks postnatal, the patient is given sufficient protection against clot formation during the critical postnatal period. This intervention is considered appropriate and effective for high-risk postnatal patients.

The correct answer is d. Female. This is because females generally have a higher risk of bleeding compared to males due to factors such as menstruation and pregnancy. Rheumatic disease and central venous catheter are known risk factors for bleeding in medical and surgical patients, while being male is considered a lesser risk factor.

Male sex is related to abdominal surgery as a specific risk factor for bleeding. This means that being male increases the likelihood of experiencing bleeding during abdominal surgery compared to being female. The explanation for this could be that males generally have a higher amount of blood vessels in the abdominal area, making them more prone to bleeding during surgical procedures. Additionally, hormonal differences between males and females may also contribute to this increased risk.